860005-21-6 Usage
Description
NCX 116 is a pharmaceutical compound that is currently under development for the treatment of various medical conditions. It is a derivative of Latanoprost, a prostaglandin analog that is commonly used to lower intraocular pressure in patients with glaucoma.
Uses
Used in Ophthalmology:
NCX 116 is used as a treatment for interocular pressure, particularly in patients with glaucoma. It works by increasing the outflow of aqueous humor, the fluid in the eye, which helps to reduce the pressure within the eye. This can help to prevent further damage to the optic nerve and slow the progression of the disease.
Check Digit Verification of cas no
The CAS Registry Mumber 860005-21-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,0,0,0 and 5 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 860005-21:
(8*8)+(7*6)+(6*0)+(5*0)+(4*0)+(3*5)+(2*2)+(1*1)=126
126 % 10 = 6
So 860005-21-6 is a valid CAS Registry Number.
860005-21-6Relevant articles and documents
PROCESS FOR THE PREPARATION OF LATANOPROSTENE BUNOD AND INTERMEDIATE THEREOF AND COMPOSITIONS COMPRISING THE SAME
-
, (2022/02/05)
Processes for preparing latanoprostene bunod and an intermediate prepared from the process. Also latanoprostene bunod compositions having high-purity latanoprostene bunod.
PROSTAGLANDIN NITROOXYDERIVATIVES
-
Page/Page column 36-37, (2008/06/13)
Prostaglandin nitrooxyderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
